MAT2A and liver cancer: The early demonstration of a SAM fall and a MAT1A/MAT2A switch during liver injury and hepatocarcinogenesis, the generation and the analysis of MAT1A-KO mice, and the demonstration of the anticancer effect of SAM treatment represent some milestones for the elucidation of the pathogenesis and the development of new therapies for liver cancer.